{"name":"ABL Bio, Inc.","slug":"abl-bio-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":4,"colorKey":"oncology","drugs":[{"name":"ABL103","genericName":"ABL103","slug":"abl103","indication":"Other","status":"phase_1"},{"name":"ABL501","genericName":"ABL501","slug":"abl501","indication":"Other","status":"phase_1"},{"name":"ABL503","genericName":"ABL503","slug":"abl503","indication":"Other","status":"phase_1"},{"name":"ABL301","genericName":"ABL301","slug":"abl301","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"ABL103","genericName":"ABL103","slug":"abl103","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"ABL501","genericName":"ABL501","slug":"abl501","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"ABL503","genericName":"ABL503","slug":"abl503","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"ABL301","genericName":"ABL301","slug":"abl301","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxOajNUWUk5eC15NFFRRWJ2aEUwRFVac08xcWdJOFRwVDBPa1U1cFFNVVRKYlRNRUdBU1hsRDZQalg0YkZXMlFocVUyT3hVRGgtSjBEaGxvYjhVRjBkaTZHaXJnNjB4Q0FXUjZTS2xmR2RaRUh6VDlYVzZrWkFOTk1NOE13SS12SExTWVVnbkFOaG5rWk82WW00V3NZVEpfNlh4bU5hV3Jn?oc=5","date":"2026-02-27","type":"deal","source":"BioCentury","summary":"Punching above its weight, Korea draws Western partners in CNS - BioCentury","headline":"Punching above its weight, Korea draws Western partners in CNS","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwgFBVV95cUxPSnZsY0xnVGhXYXlweXFHYmFCaHNWY2UtU2ZHV29EQWttYzRpRlV6UndpNmJRa2ZyaG81eUFfajRQNmFRVWdqRVRZZmUwZEVxU0ZUMDQ0LWRVQ3VmZ2tzYkhDOXNwZlBYYkkzcklOMWV2TngyWE1WSC1OcWhaaDZSeTFQNmxvOEdLc1VfeFhTMU95M1l6SmtMOTFpMy14YUYxS0lPTzlxeXFYdnh6R2lTWXJZankzR1dfMk5kV1ROUHIxQQ?oc=5","date":"2026-02-22","type":"pipeline","source":"Smartkarma","summary":"APAC Healthcare Weekly (February 22) – Sino Bio, Hansoh Pharma, Daiichi Sankyo, Ono, ABL Bio, CSL - Smartkarma","headline":"APAC Healthcare Weekly (February 22) – Sino Bio, Hansoh Pharma, Daiichi Sankyo, Ono, ABL Bio, CSL","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiV0FVX3lxTFAzaXoydHFxYU9COXQ0cFFyeGVkaDBtOWhndXI3eGZGSjdHLS0zUFZGYkRwWDJxaTFfNW83ajFqalJqakcyTG8yQnZmZmVqd0J0anJPTGgwTQ?oc=5","date":"2026-01-16","type":"deal","source":"The Korea Herald","summary":"[JPM 2026] ABL Bio seeks next license-out after GSK, Eli Lilly deals - The Korea Herald","headline":"[JPM 2026] ABL Bio seeks next license-out after GSK, Eli Lilly deals","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiYEFVX3lxTFB3dDZzTnlpZjFsZ0E1QVRtRFJQdGRiNklURGRYN1VjcGJheXo4blBjQk03Y1pxenVrXzBDZGZrZWxqeS1wTWJsc0dGVVJ2T2laU1hOem1XQ0dJSmtJSjNYRQ?oc=5","date":"2025-11-18","type":"pipeline","source":"동아비즈니스리뷰 | DBR","summary":"\"Korean Bio Platforms Attract Global Pharma Interest\" - 동아비즈니스리뷰 | DBR","headline":"\"Korean Bio Platforms Attract Global Pharma Interest\" - 동아비즈니스리뷰 | DBR","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTE4wN1RDR1pEQlJvYUxoZ0UweVFuNVZwdEZfVS1xZGRlbmhoV0VHUVBpNU9SY25iS0Y0Z0NMVHBLbGFpbnFMVUZ2TXUyZXdkZFlFN3NZ?oc=5","date":"2025-11-17","type":"pipeline","source":"FirstWord Pharma","summary":"Lilly takes $15M stake in ABL Bio, bets up to $2.6B on its bispecifics - FirstWord Pharma","headline":"Lilly takes $15M stake in ABL Bio, bets up to $2.6B on its bispecifics","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiswFBVV95cUxOZHlOcWIxbFJTMmVveGRtakNZMmZtdHdvd3I1U295UU10TVg3OHlVNVFyX3BIWVItRzR0TjJvcUM4aWpJcjhwOUUtZHN5a0E2SWl4T0hGMUdaRFliWUdDdzNrVnNlV0dtaXl0UGkydUZwSXNmc0pDMzh0cl85R1NWei03c2VhZDZaYlFBekJBSnBZTFpoVF9saFNXRk5DcU85SnF4c3kzMFR0UndPZzI2U1NqWQ?oc=5","date":"2025-11-17","type":"pipeline","source":"BioSpace","summary":"Lilly Bets More Than $2.6B for South Korea Biotech’s Bispecific Antibody Platform - BioSpace","headline":"Lilly Bets More Than $2.6B for South Korea Biotech’s Bispecific Antibody Platform","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE9KQWhqVVZoSTVoa0tMS3FWbjg2RWN1bjVicXpmOXZYWkJpbzB6SWlHeGhFUUN2NHBnQWJqNHFkOTBiZGtscEE3LU12RHpCQlQ0T2NrSTNaRlI5QldFOGtPby0tSjNjeWhEazFXcjlB0gFyQVVfeXFMTlFqaTF3ZkFLQ2tvRkdITTdlVUxxdDE5SklwSHhlZHI1N2R6SlVrZ3JUYmtmbmZuUnRJdGg2c184aFNHLVg4QXJkU2ljTDZ4bGQzWlYtMzZTVTJIbjhDeGlDRF9ORF9Xcmw1QkJ6b1RtVEdB?oc=5","date":"2025-11-17","type":"deal","source":"koreabiomed.com","summary":"ABL Bio seals $2.6 bil. Lilly brain-drug deal and $15m mil. stake to back new cancer drugs - koreabiomed.com","headline":"ABL Bio seals $2.6 bil. Lilly brain-drug deal and $15m mil. stake to back new cancer drugs","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxNZDdrNDJkX0lGUGpnZldNT2RXRG55TnFweVdHN1lyMGJ1cmJSbEFBVmp2XzM3eGU2RDIzdWlaNTk5NU9MVmEtNXhrd1RxQTRPbFlNQWlPMHJ0azFLck1KQko4MXVSTXRrTDhmMWxYV296RGJEWDM0TG9kUUZaUE1mR3ptMk5qUmV1N215MmlmZ0lLTGVDWW9EY2g5OEI0VUFCTk5LYQ?oc=5","date":"2025-11-13","type":"deal","source":"BioCentury","summary":"Brain shuttle field accelerates with three more pharma deals - BioCentury","headline":"Brain shuttle field accelerates with three more pharma deals","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE5YN09mNTlhbWt1VXdiMjlVeEl5azkzcWtPU2oydzNSV0ZZMjJ6SzJXa0dmQXBacTNQaEJFNFZsc0Y2NG1MTGpBR3dYRmg3RGtjb2hnejVBNlJLZnJaSG5Wa3JEbnBwUlZuN2NIVUpB?oc=5","date":"2025-11-12","type":"deal","source":"KED Global","summary":"ABL Bio lands $2.6 bn Eli Lilly deal, capping record year for S.Korean biotech exports - KED Global","headline":"ABL Bio lands $2.6 bn Eli Lilly deal, capping record year for S.Korean biotech exports","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxQRkRGX2dKSm9NV3M4YTNwcjZ0VkUzZFRZVF8tdDVHNDhhY3FPYnZ2ZWVuWC1CcVZrWGxBZ1BCWng3dXZ3NVJkUDAwa3p5eHBjSnRrVXd6dFJRT04yeVU3aVJqMTJQSVpBaGZLbGpkZERUdjJmdG1jTDdBNUQzRXBzU3pRMjNJc20xeExvTDQyTXJUQVZRcUJBeDRB?oc=5","date":"2025-11-05","type":"pipeline","source":"BioWorld News","summary":"Neok Bio launches with $75M to develop bispecific ADCs - BioWorld News","headline":"Neok Bio launches with $75M to develop bispecific ADCs","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxONFFZbEhpUXByMTFtd1I3YlMtT1kzdU1KRWtwWEVPeTBXX3pWTzBLTmZ0OFRhQ3FMUFVpN3dsM0FzMnlaR0tCQ2pPQUNhcGxKQUIwb2ZzaUJpLWJsQVlxSjNGUUhmMVlDYm1aZk13b3FoZ1hBYW1UN3hkUE5YaHRQTXoyRFVMbGMxS3g4VG1HU1JjY2RzY080bA?oc=5","date":"2025-11-04","type":"pipeline","source":"BioPharma Dive","summary":"Neok Bio launches with $75M to make dual-targeting ADCs - BioPharma Dive","headline":"Neok Bio launches with $75M to make dual-targeting ADCs","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAJBVV95cUxQNkRXXzNSMEowdzJ4bjhheVpFS01wYXFwVUw1YzFQZFltYmhOUUtEOTRfUm9wV2hGdC0yVE9zelRZWDVtaWVfVHFocnU4UnF3SmRienZHUXo2ZXF2Z3EwYUR5NnZGVWoxRFNPMi16RUt6dFN3WmdHMWsxeGxOWGJBMWgyR2pmQ0xpNGczQUFBTW5RMmxPa3ZST3kwMGZXSFNrN2Y1Y3VUVy1Ia2dzbHBUX1VwOUpqY2xPMWhtRkUxVFMwOU5OdkM0a3A1TTRiRHpTTHJ0ZG9uLTRpeElXdGNCNmhKcXFVSEdLX1BRODlpZjhwQjN6RXl6cWlRRENZdTJVMGtRaUhkUTAwUFNyRUI0R1dFVkxVZHAxdnRPSw?oc=5","date":"2025-04-06","type":"deal","source":"PR Newswire","summary":"ABL Bio Announces Grabody-B Brain Delivery Platform License Agreement with GSK to Develop Novel Medicines for Neurodegenerative Diseases - PR Newswire","headline":"ABL Bio Announces Grabody-B Brain Delivery Platform License Agreement with GSK to Develop Novel Medicines for Neurodegen","sentiment":"neutral"}],"patents":[],"drugCount":4,"phaseCounts":{"phase_1":4},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}